These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 17897075)

  • 1. Bioactivity of new mu and delta opioid peptides.
    Capasso A
    Med Chem; 2007 Sep; 3(5):480-7. PubMed ID: 17897075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid receptor selectivity alteration by single residue replacement: synthesis and activity profile of [Dmt1]deltorphin B.
    Guerrini R; Capasso A; Sorrentino L; Anacardio R; Bryant SD; Lazarus LH; Attila M; Salvadori S
    Eur J Pharmacol; 1996 Apr; 302(1-3):37-42. PubMed ID: 8790989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dmt-Tic-OH a highly selective and potent delta-opioid dipeptide receptor antagonist after systemic administration in the mouse.
    Capasso A; Guerrini R; Balboni G; Sorrentino L; Temussi P; Lazarus LH; Bryant SD; Salvadori S
    Life Sci; 1996; 59(8):PL93-8. PubMed ID: 8761022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides.
    Salvadori S; Attila M; Balboni G; Bianchi C; Bryant SD; Crescenzi O; Guerrini R; Picone D; Tancredi T; Temussi PA
    Mol Med; 1995 Sep; 1(6):678-89. PubMed ID: 8529134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
    J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
    Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
    Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice.
    Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F
    Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison with naloxone of two dynorphin A analogues with K- and delta-opioid antagonist activity.
    Capasso A
    Med Chem; 2009 Jan; 5(1):1-6. PubMed ID: 19149644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Dmt-Tic pharmacophore: conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties.
    Balboni G; Guerrini R; Salvadori S; Bianchi C; Rizzi D; Bryant SD; Lazarus LH
    J Med Chem; 2002 Jan; 45(3):713-20. PubMed ID: 11806723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformationally restricted deltorphin analogues.
    Schiller PW; Weltrowska G; Nguyen TM; Wilkes BC; Chung NN; Lemieux C
    J Med Chem; 1992 Oct; 35(21):3956-61. PubMed ID: 1331451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists.
    Schiller PW; Nguyen TM; Weltrowska G; Wilkes BC; Marsden BJ; Lemieux C; Chung NN
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11871-5. PubMed ID: 1334552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (2S,3R) beta-methyl-2',6'-dimethyltyrosine-L-tetrahydroisoquinoline-3-carboxylic acid [(2S,3R)TMT-L-Tic-OH] is a potent, selective delta-opioid receptor antagonist in mouse brain.
    Hosohata K; Varga EV; Alfaro-Lopez J; Tang X; Vanderah TW; Porreca F; Hruby VJ; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 2003 Feb; 304(2):683-8. PubMed ID: 12538822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive and behavioral effects of synthetic deltorphin analogs.
    Negri L; Noviello L; Noviello V
    Eur J Pharmacol; 1996 Jan; 296(1):9-16. PubMed ID: 8720471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of mu selective opioid dipeptide antagonists.
    Capasso A; Amodeo P; Balboni G; Guerrini R; Lazarus LH; Temussi PA; Salvadori S
    FEBS Lett; 1997 Nov; 417(1):141-4. PubMed ID: 9395092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal guanidinylation of TIPP (Tyr-Tic-Phe-Phe) peptides results in major changes of the opioid activity profile.
    Weltrowska G; Nguyen TM; Chung NN; Wilkes BC; Schiller PW
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5082-5. PubMed ID: 23932788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of delta-, kappa- and mu-receptor selective opioid peptide agonists into delta-, kappa- and mu-selective antagonists.
    Schiller PW; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Lu Y
    Life Sci; 2003 Jun; 73(6):691-8. PubMed ID: 12801590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
    Schmidt R; Wilkes BC; Chung NN; Lemieux C; Schiller PW
    Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dmt(1)]DALDA is highly selective and potent at mu opioid receptors, but is not cross-tolerant with systemic morphine.
    Riba P; Ben Y; Nguyen TM; Furst S; Schiller PW; Lee NM
    Curr Med Chem; 2002 Jan; 9(1):31-9. PubMed ID: 11860345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further studies on the Dmt-Tic pharmacophore: hydrophobic substituents at the C-terminus endow delta antagonists to manifest mu agonism or mu antagonism.
    Salvadori S; Guerrini R; Balboni G; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
    J Med Chem; 1999 Dec; 42(24):5010-9. PubMed ID: 10585210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
    Hammond DL; Wang H; Nakashima N; Basbaum AI
    J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.